Key Transactions

Chakr Innovation Private Limited

Capital Raise

USD 23 mn

FY26

Exclusive financial advisor to Chakr Innovation on its Series C fundraise

Ambit acted as the exclusive financial advisor to Chakr Innovation on its USD 23Mn Series C fundraise led by Iron Pillar, along with participation from existing investor - SBI Cap Ventures

Exclusive financial advisor to Chakr Innovation on its Series C fundraise

Ambit acted as the exclusive financial advisor to Chakr Innovation on its USD 23Mn Series C fundraise led by Iron Pillar, along with participation from existing investor - SBI Cap Ventures

KKR & OTPP

ECM

INR 25 bn

FY26

Sale of PE Investor's stake

Ambit acted as the Advisor and Broker to KKR & OTPP for their stake sale in Vertis Infrastructure Trust

Sale of PE Investor's stake

Ambit acted as the Advisor and Broker to KKR & OTPP for their stake sale in Vertis Infrastructure Trust

Brookfield (Sponsor of Energy Infrastructure Trust)

ECM

INR 18 bn

FY26

Sale of PE Investor's stake

Ambit acted as the Advisor and Broker to Brookfield for their stake sale in Energy Infrastructure Trust

Sale of PE Investor's stake

Ambit acted as the Advisor and Broker to Brookfield for their stake sale in Energy Infrastructure Trust

investcorp-(unitholder-of-ndr-invit-trust)

ECM

INR 3 bn

FY26

Sale of Investor's stake

Ambit acted as the Advisor and Broker to Investcorp for their stake sale in NDR InvIT Trust

Sale of Investor's stake

Ambit acted as the Advisor and Broker to Investcorp for their stake sale in NDR InvIT Trust

Mantra Softech (India) Private Limited

Capital Raise

USD 14 mn

FY26

Exclusive financial advisor to Mantra Group on its USD 14 mn fundraise

Ambit acted as an exclusive financial advisor to Mantra Group "Mantra" on its USD 14 mn fundraise round from India SME Investments and Motilal Oswal Principal Investments

Exclusive financial advisor to Mantra Group on its USD 14 mn fundraise

Ambit acted as an exclusive financial advisor to Mantra Group "Mantra" on its USD 14 mn fundraise round from India SME Investments and Motilal Oswal Principal Investments

FSP Design Private Limited

M&A

NA

FY26

Exclusive financial advisor to FSP Design Pvt. Ltd. and its shareholders on stake sale

Ambit acted Exclusive financial advisor to FSP Design Pvt. Ltd. and its shareholders on their strategic stake sale (40%) to RPSG Ventures for an Enterprise Value of INR 455 Cr

Exclusive financial advisor to FSP Design Pvt. Ltd. and its shareholders on stake sale

Ambit acted Exclusive financial advisor to FSP Design Pvt. Ltd. and its shareholders on their strategic stake sale (40%) to RPSG Ventures for an Enterprise Value of INR 455 Cr

Société BIC SA

M&A

INR 1.5 bn

FY26

Exclusive financial advisor to Société BIC on sale of its subsidiary BIC Cello (India) Pvt. Ltd.

Ambit acted as the exclusive financial advisor to to Société BIC on sale of its subsidiary BIC Cello (India) Pvt. Ltd. to buyer consortium led by Authum Investment & Infrastructure Ltd.

Exclusive financial advisor to Société BIC on sale of its subsidiary BIC Cello (India) Pvt. Ltd.

Ambit acted as the exclusive financial advisor to to Société BIC on sale of its subsidiary BIC Cello (India) Pvt. Ltd. to buyer consortium led by Authum Investment & Infrastructure Ltd.

nephrocare-health-services-limited

ECM

INR 10 bn

FY26

Book Running Lead Manager for IPO of Nephrocare Health Services Limited

Ambit acted as a BRLM to the c.INR 10 bn IPO consisting of secondary pre-IPO of INR 1.36 bn, a Fresh Issue of INR 3.53 bn and an Offer for Sale of INR 5.18 bn.The anchor book witnessed participation from Tier 1 MFs as well as Long Only FIIs, showcasing strong Investor conviction in the Nephroplus story

Book Running Lead Manager for IPO of Nephrocare Health Services Limited

Ambit acted as a BRLM to the c.INR 10 bn IPO consisting of secondary pre-IPO of INR 1.36 bn, a Fresh Issue of INR 3.53 bn and an Offer for Sale of INR 5.18 bn.The anchor book witnessed participation from Tier 1 MFs as well as Long Only FIIs, showcasing strong Investor conviction in the Nephroplus story

Serum-Institute-Life-Sciences-Tata-Capital-Healthcare-Fund

M&A

INR 25 bn

FY26

Exclusive Financial Advisor to Serum Institute & Tata Capital

Ambit acted as Exclusive Financial Advisor to Serum Institute & Tata Capital on their ~25bn divestment in Biocon Biologics

Exclusive Financial Advisor to Serum Institute & Tata Capital

Ambit acted as Exclusive Financial Advisor to Serum Institute & Tata Capital on their ~25bn divestment in Biocon Biologics